Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis.
Doundoulakis I, Gavriilaki M, Tsiachris D, Arsenos P, Antoniou CK, Dimou S, Soulaidopoulos S, Farmakis I, Akrivos E, Stoiloudis P, Notas K, Kimiskidis VK, Giannakoulas G, Paraskevaidis S, Gatzoulis KA, Tsioufis K. Doundoulakis I, et al. Among authors: farmakis i. Cardiovasc Drugs Ther. 2022 Oct;36(5):951-958. doi: 10.1007/s10557-021-07209-8. Epub 2021 Jun 5. Cardiovasc Drugs Ther. 2022. PMID: 34089429 Review.
Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design.
Boulmpou A, Kartas A, Farmakis I, Zafeiropoulos S, Nevras V, Papadimitriou I, Tampaki A, Vlachou A, Lillis L, Koutsakis A, Karvounis H, Giannakoulas G. Boulmpou A, et al. Among authors: farmakis i. Hellenic J Cardiol. 2019 Jul-Aug;60(4):249-253. doi: 10.1016/j.hjc.2018.10.002. Epub 2018 Oct 21. Hellenic J Cardiol. 2019. PMID: 30352291 Free article. Clinical Trial.
Low-density lipoprotein cholesterol target value attainment based on 2019 ESC/EAS guidelines and lipid-lowering therapy titration for patients with acute coronary syndrome.
Farmakis I, Zafeiropoulos S, Pagiantza A, Boulmpou A, Arvanitaki A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Karvounis H, Giannakoulas G. Farmakis I, et al. Eur J Prev Cardiol. 2020 Dec;27(19):2314-2317. doi: 10.1177/2047487319891780. Epub 2019 Dec 9. Eur J Prev Cardiol. 2020. PMID: 31818140 No abstract available.
Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome.
Zafeiropoulos S, Farmakis I, Kartas A, Arvanitaki A, Pagiantza A, Boulmpou A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Arvanitakis K, Sianos G, Makedou K, Ziakas A, Tzikas A, Karvounis H, Giannakoulas G. Zafeiropoulos S, et al. Among authors: farmakis i. Am J Cardiol. 2020 Oct 15;133:7-14. doi: 10.1016/j.amjcard.2020.07.046. Epub 2020 Jul 28. Am J Cardiol. 2020. PMID: 32828524
Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.
Zafeiropoulos S, Farmakis I, Kartas A, Arvanitaki A, Pagiantza A, Boulmpou A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Vlachou A, Arvanitakis K, Miyara SJ, Ziakas A, Molmenti EP, Kassimis G, Zanos S, Karvounis H, Giannakoulas G. Zafeiropoulos S, et al. Among authors: farmakis i. Atherosclerosis. 2021 Apr;323:37-43. doi: 10.1016/j.atherosclerosis.2021.03.013. Epub 2021 Mar 17. Atherosclerosis. 2021. PMID: 33780749 Clinical Trial.
76 results